BR112018069279A2 - métodos analíticos e matrizes para uso no mesmo - Google Patents

métodos analíticos e matrizes para uso no mesmo

Info

Publication number
BR112018069279A2
BR112018069279A2 BR112018069279A BR112018069279A BR112018069279A2 BR 112018069279 A2 BR112018069279 A2 BR 112018069279A2 BR 112018069279 A BR112018069279 A BR 112018069279A BR 112018069279 A BR112018069279 A BR 112018069279A BR 112018069279 A2 BR112018069279 A2 BR 112018069279A2
Authority
BR
Brazil
Prior art keywords
matrices
analytical methods
methods
analytical
kits
Prior art date
Application number
BR112018069279A
Other languages
English (en)
Inventor
Chawade Aakash
Andreas Sebastian Forreryd Andy
Albrekt Ann-Sofie
A K Borrebaeck Carl
Johansson Henrik
Stephanie Zeller Kathrin
Marie Lindstedt Malin
Carl Sewe Lindberg Tim
Original Assignee
Senzagen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1700138.9A external-priority patent/GB201700138D0/en
Application filed by Senzagen Ab filed Critical Senzagen Ab
Publication of BR112018069279A2 publication Critical patent/BR112018069279A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/763—Herpes virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds

Abstract

a presente invenção refere-se a um método para identi-ficar a potência de sensibilizador de pele de um agente de teste, e matrizes e kits analíticos para uso em tais méto-dos.
BR112018069279A 2016-03-23 2017-03-22 métodos analíticos e matrizes para uso no mesmo BR112018069279A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2016056465 2016-03-23
GBGB1700138.9A GB201700138D0 (en) 2017-01-05 2017-01-05 Analytical methods and arrays for use in the same
PCT/EP2017/056878 WO2017162773A1 (en) 2016-03-23 2017-03-22 Analytical methods and arrays for use in the same

Publications (1)

Publication Number Publication Date
BR112018069279A2 true BR112018069279A2 (pt) 2019-01-22

Family

ID=58410306

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018069279A BR112018069279A2 (pt) 2016-03-23 2017-03-22 métodos analíticos e matrizes para uso no mesmo

Country Status (12)

Country Link
EP (2) EP3417074B1 (pt)
JP (2) JP7023857B2 (pt)
KR (1) KR102402479B1 (pt)
CN (1) CN108884493B (pt)
AU (1) AU2017238455B2 (pt)
BR (1) BR112018069279A2 (pt)
CA (1) CA3017270A1 (pt)
DK (2) DK3417074T3 (pt)
ES (2) ES2745580T3 (pt)
IL (1) IL261835B2 (pt)
TW (1) TW201805430A (pt)
WO (1) WO2017162773A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3417074T3 (da) * 2016-03-23 2019-09-16 Senzagen Ab Analytiske fremgangsmåder og arrays til bestemmelse af den hudsensibiliserende virkning af midler in vitro
GB201715445D0 (en) 2017-09-25 2017-11-08 Senzagen Ab Novel cell line and uses thereof
CN110794047A (zh) * 2019-09-30 2020-02-14 广州市华代生物科技有限公司 一种复杂受试物对皮肤致敏性的预测方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3169789D1 (en) 1980-05-02 1985-05-15 Edward P Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
EP1905843A1 (en) * 2006-09-29 2008-04-02 Vlaamse Instelling voor Technologisch Onderzoek Method for determining the allergic potential of a compound
JP5442185B2 (ja) * 2007-04-24 2014-03-12 日本メナード化粧品株式会社 感作性物質評価方法
WO2009148669A1 (en) * 2008-06-04 2009-12-10 Ceetox, Inc. Method for predicting skin sensitizing activity of compounds
GB201018014D0 (en) * 2010-10-26 2010-12-08 Senzagen Ab Analytical methods and arrays for use in the same
US20140213466A1 (en) * 2010-11-19 2014-07-31 Rutgers, The State University Of New Jersey High-throughput assessment method for contact hypersensitivity
GB201110371D0 (en) * 2011-06-17 2011-08-03 Proteome Sciences R & D Gmbh & Co Kg Materials and methods for determining sensitivity potential of compounds
GB201207297D0 (en) * 2012-04-26 2012-06-06 Senzagen Ab Analytical methods and arrays for use in the same
EP2835640A1 (en) * 2013-08-06 2015-02-11 Academisch Ziekenhuis Leiden HODN Leids Universitair Medisch Centrum Method for predicting the skin sensitizing activity of a compound.
JP6378529B2 (ja) * 2014-04-28 2018-08-22 国立大学法人 鹿児島大学 遺伝性疾患の検出方法
DK3417074T3 (da) * 2016-03-23 2019-09-16 Senzagen Ab Analytiske fremgangsmåder og arrays til bestemmelse af den hudsensibiliserende virkning af midler in vitro

Also Published As

Publication number Publication date
CN108884493B (zh) 2022-07-19
EP3417074B1 (en) 2019-06-12
JP7261852B2 (ja) 2023-04-20
JP2022009855A (ja) 2022-01-14
EP3536805A3 (en) 2019-09-25
DK3417074T3 (da) 2019-09-16
KR102402479B1 (ko) 2022-05-25
JP2019516950A (ja) 2019-06-20
AU2017238455A1 (en) 2018-10-04
IL261835A (en) 2018-10-31
CA3017270A1 (en) 2017-09-28
IL261835B2 (en) 2023-03-01
WO2017162773A1 (en) 2017-09-28
AU2017238455B2 (en) 2023-01-19
EP3536805A2 (en) 2019-09-11
ES2745580T3 (es) 2020-03-02
EP3417074A1 (en) 2018-12-26
IL261835B (en) 2022-11-01
TW201805430A (zh) 2018-02-16
JP7023857B2 (ja) 2022-02-22
CN108884493A (zh) 2018-11-23
DK3536805T3 (en) 2022-11-14
EP3536805B1 (en) 2022-11-02
ES2934349T3 (es) 2023-02-21
KR20180128422A (ko) 2018-12-03

Similar Documents

Publication Publication Date Title
BR112018005164A2 (pt) anticorpos, ácido nucleico, célula hospedeira, método para produzir um anticorpo, formulação farmacêutica, uso do anticorpo e método de tratamento de um indivíduo que tem câncer
CL2020000281A1 (es) Anticuerpos anti-cd39, composiciones que comprenden anticuerpos anti-cd39 y métodos de uso de anticuerpos anti-cd39
CO2019003154A2 (es) Anticuerpos anti-pd-1 y sus usos
CL2019001646A1 (es) Anticuerpos anti-ox40 y sus usos.
AR107781A1 (es) Moléculas biespecíficas que tienen inmunorreactividad con pd-1 y ctla-4, y métodos de uso de las mismas
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
BR112018000768A2 (pt) anticorpos anti-pd-1, anticorpos anti-pd-1 ativáveis e métodos de uso dos mesmos
BR112017008914A2 (pt) método para tratar câncer, composição e uso da composição
BR112017010406A2 (pt) processo de realização de teste de alta produtividade de cromatografia líquida de alta eficiência
EP3355054A4 (en) METHOD, DEVICE AND APPLICATION FOR SIMULATED INTERNAL STANDARD FOR QUANTITATIVE ANALYSIS IN MASS SPECTROMETRY
MX2021005353A (es) Composiciones, metodos y sistemas para el analisis de la corona proteica y usos de los mismos.
AR100215A1 (es) Conjugados de anticuerpo-fármaco anti-ptk7
CR20160362A (es) Anticuerpos anti-jagged1 y metodos de uso
CL2017002604A1 (es) Sondas duales silenciadoras
MX2018013621A (es) Metodo, matriz y uso de estos.
AR105910A1 (es) Matrices de glicano y método de uso
TR201907737T4 (tr) Test numunesi desteği ve çarpışma testi aparatı ve destek kullanılarak yapısal elemanın çarpışma testi yöntemi.
MX2019008911A (es) Metodos, matrices y usos de estos.
EP3459424A4 (en) CANCER TEST DEVICE, CANCER TEST METHOD AND COLORING AGENT FOR USE IN CANCER TESTING
EP3351934A4 (en) Cancer development risk assessment device, program, and method for testing cancer development risk
BR112018069279A2 (pt) métodos analíticos e matrizes para uso no mesmo
BR112017011026A2 (pt) métodos analíticos e arranjos para uso nos mesmos
CL2020000248A1 (es) Sistemas y métodos para la preparación en tiempo real de una muestra de polipéptidos para el análisis por espectrometría de masas.
EP3428645A4 (en) KIT FOR SIMPLE SPERM TEST, SYSTEM AND METHOD FOR CARRYING OUT A SIMPLE TEST ON SPERM
SE1651485A1 (sv) Method and system for vehicle analysis

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]